Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDI Study of D-2570 in Healthy Participants
NCT07875842Phase 1Not yet recruiting
- Sponsor
- InventisBio
- Start
- Sep 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 1, open-label trial of D-2570 in psoriasis (4 arms), sponsored by InventisBio. Primary endpoints: Maximum observed plasma concentration and Area under the plasma concentration versus time curve. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
D-2570
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT07875842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07875842.